ScopusElsevier Scopus
Status
Active
Coverage
2008–2026
Source type
Journal
Open access
Yes
CiteScore
4.2
Best quartile
Q2 · 65th pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 53 / 151 | 65th | Q2 |
| Oncology | 207 / 428 | 51st | Q2 |
Hematology/ Oncology and Stem Cell Therapy
ISSN 1658-3876 · 2589-0646
Publisher: Wolters Kluwer Health
Scopus · Q2Open Access
Is Hematology/ Oncology and Stem Cell Therapy indexed in Scopus? Yes — actively indexed in Scopus, coverage 2008–2026, best quartile Q2, CiteScore 4.2.
Is Hematology/ Oncology and Stem Cell Therapy in Web of Science? No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Hematology/ Oncology and Stem Cell Therapy open access? Yes — it is an open-access journal, listed in DOAJ.
4.2
CiteScore 2025
Scopus
Q2
Best quartile
65th percentile
2
Indexed in
major indexes
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
Not listed in Web of Science.
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Checking DOAJ…
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.
Official sources & links
Related journals
Explore this journal in the interactive dashboard →
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.